ArticleDiscover oncology2025

A novel prognostic risk score associated with resistance to docetaxel chemotherapy for predicting biochemical recurrence-free survival in patients with prostate cancer.

Desheng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.